Announced
Completed
Synopsis
Gradient Ventures, a venture capital firm, and ClearHaven Capital, a global investment company, led a $110m Series A round in Walnut, a healthcare fintech company, with participation from Newark Ventures, Afore Capital, 2048 Ventures, AngelList, Weekend Fund, Company Ventures, Banana Capital, Goodwater Capital and Muse Capital. “We describe this as ‘buy now, pay later’ for healthcare. By enabling patients to pay in monthly installments, we alleviate their financial burden to help them afford and access the care they need,” Walnut.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.